Rare diseases
Investigational molecules
Locations
378 conditions with trials, the busiest first
838 trials across Europe, recruiting first
Study on the Safety and Tolerability of Exidavnemab in Patients with Mild to Moderate Parkinson's Disease
PolandStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
AustriaLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
AustriaStudy on the Safety and Tolerability of Guanabenz in Children with Vanishing White Matter Disease
The NetherlandsLong-term Safety Study of INZ-701 for Patients with ENPP1 and ABCC6 Deficiencies, Including Pseudoxanthoma Elasticum and Generalized Arterial Calcification of Infancy
FranceStudy on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units
GermanyStudy of SPI-62 for Treating ACTH-Dependent Cushing's Syndrome in Patients with Cushing's Disease or Ectopic ACTH/CRH Secretion
BulgariaStudy of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication
FranceStudy on the Effectiveness of Fremanezumab for Preventing Migraines in Children and Teens Aged 6 to 17
FinlandStudy on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis
FranceStudy on the Effects of Dexmedetomidine on Neuroinflammation in COVID-19 ARDS Survivors
FranceStudy on Esflurbiprofen and Paracetamol for Pain Relief in Patients with Limb Bruises
GermanyThe therapies tested most often in Vascular disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
